Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07095790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke

Study acronym: TiMIS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to evaluate whether initiating intravenous tirofiban within 48 hours of onset (with a 48-hour infusion), followed by sequential DAPT, can improve the likelihood of excellent functional outcomes (modified Rankin Scale score 0-1) in mild stroke patients, compared with standard DAPT therapy based on current guidelines.
Trial Details
NCT Number NCT07095790
Lead Sponsor Second Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 Mild Stroke
Enrollment 580 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov